US Patent 7291455 Assessment of human papilloma virus-related disease
Patent 7291455 was granted and assigned to Digene on November, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+260 characters)
Article
Patent abstract
This invention provides novel methods for assessing HPV infection. Gene expression levels are used to assess the progression of HPV infection from benign to malignant growth. Also provided are kits for carrying out the methods of this invention.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07291455 Assessment of human papilloma virus-related disease US Patent 7291455 Assessment of human papilloma virus-related disease
Infobox
Patent Number
0729145500
Patent Number
729145500
Edits on 2 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072914550
Date of Patent
November 6, 2007
0Patent Application Number
099704770
Date Filed
October 4, 2001
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072914550
Date of Patent
November 6, 2007
0Patent Application Number
099704770
Date Filed
October 4, 2001
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07291455 Assessment of human papilloma virus-related disease
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07291455
Date of patent
November 6, 2007
Patent application number
09970477
Date Filed
October 4, 2001
Patent primary examiner
Find more entities like US Patent 7291455 Assessment of human papilloma virus-related disease
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.